UNH Stock Recent News
UNH LATEST HEADLINES
Investors are increasingly scrutinizing company earnings as market volatility continues to shape investment strategies. Amid this climate, key figures like Jim Cramer are vocal about their preferences, emphasizing growth potential and stability in their stock picks.
Warren Buffett's Berkshire Hathaway stake in UnitedHealth reaffirms my strong buy rating, seeing long-term value despite recent volatility. UNH faces headwinds: earnings misses, revised guidance, and higher medical costs, but maintains strong revenue growth in key segments. The 2.76% dividend yield, robust cash flows, and a solid balance sheet make UNH attractive for dividend and long-term investors.
UNH rises over 20 points after alert at 10:12 am EDT
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Major U.S. equities indexes advanced to record closing highs after the Bureau of Labor Statistics announced a significant downward revision in job growth between March 2024 and March 2025.
Some healthcare names are flashing technical buy signals.
UnitedHealth (UNH) remains more than 40% off all-time highs but is also about 50% off 52-week lows. George Tsilis says the company reaffirming EPS guidance gave investors a strong signal to take on shares.
Shares of UnitedHealth Group (UNH 9.21%) are rising on Tuesday, up 8.8% as of 2:23 p.m. ET. The jump comes as the S&P 500 and the Nasdaq Composite ticked up slightly.
UnitedHealth Group (UNH) was the best-performing stock in the Dow Jones Industrial Average and the S&P 500 on Tuesday after the health care giant said the vast majority of its Medicare Advantage enrollees are likely to qualify for bonus payments from the federal government.
UnitedHealth's stock is surging, which is giving a nice boost to Warren Buffett's new 5-million-share stake in the health insurer.